Pages

Look Towards A New Future

Aug 9, 2010

GlaxoSmithKline plc: PharmaVitae Profile now available at ReportsandReports

Dallas, TX: ReportsandReports announce it will carry GlaxoSmithKline plc: PharmaVitae Profile Market Research Report in its Store.

Browse complete GlaxoSmithKline plc: PharmaVitae Profile Report

This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

  • Benchmark GlaxoSmithKline’s performance against key rivals in the prescription pharmaceutical sector
  • Assess the threat posed by generic competition to GlaxoSmithKline’s core prescription pharmaceutical business
  • Analyze the future strategic direction of GSK, namely an enhanced vaccine offering, geographic diversification and increased biologics presence

Table Of contents

ABOUT DATAMONITOR HEALTHCARE 2

About the PharmaVitae team 2

Chapter 1 About this profile 3

PharmaVitae Explorer database 3

Chapter structure 3

Executive summary 3

Quarterly news update 3

Company introduction 3

Company sales 4

Company financials 4

Key products and competitors 4

Data sourcing 4

Sales data 4

Analyst consensus 4

Chapter 2 Executive summary 5

Key findings 5

Prescription pharmaceutical sales and growth rate performance, 2002-14 6

Financial performance, 2002-14 7

GlaxoSmithKline: PharmaVitae forecasts at a glance 8

Strategic insight 9

Introduction 9

Analysis of sales performance 2002-08 9

Analysis of sales performance 2008-14 10

Outlook 14

SWOT analysis 16

Strengths 17

Weaknesses 18

Opportunities 18

Threats 20

Table of Contents 22

Table of figures 24

Chapter 3 Quarterly news update 25

Product developments 25

Deals and alliances 27

Product deals 27

Technology deals 32

M&A activity 33

Company announcements 33

Future product milestones 35

Chapter 4 Company introduction 38

Key findings 38

Background 39

M&A history 39

Glaxo and Wellcome 39

Glaxo Wellcome 39

Smith Kline and Beecham 39

SmithKline Beecham 40

Key historical drug launches by component GSK companies 41

M&A strategy 41

R&D overview 44

Chapter 5 Company sales 46

Key findings 46

Prescription pharmaceutical sales and growth rate analysis, 2002-14 47

Product analysis 49

Product analysis, 2002-08 50

Product analysis, 2008-14 53

Therapy area analysis 56

Geographic analysis 59

Launch/core/expiry analysis 61

Explanation of launch/core/expiry analysis 61

Launch analysis, 2008-14 62

Core analysis, 2008-14 65

Expiry analysis, 2008-14 66

Launch/core/expiry configuration, 2008-14 68

Molecule type analysis 69

Externalization analysis 73

Chapter 6 Company financials 76

Key findings 76

Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08 77

Operating costs and profit analysis 78

Operating costs and profit analysis, 2002-08 79

Operating cost ratio and profit margin analysis, 2002-08 80

Operating cost ratio and profit margin analysis, 2008-14 81

Operating costs and profit analysis, 2008-14 82

Chapter 7 Key products and competitors 83

Overview 83

Respiratory 84

Seretide/Advair 84

Overview 84

Sales forecast 85

Beyond Advair 87

Overview 87

Sales forecast 88

Infectious diseases 89

Cervarix 89

Overview 89

Sales forecast 90

Valtrex 93

Overview 93

Sales forecast 94

Oncology 95

Tykerb/Tyverb 95

Overview 95

Sales forecast 96

Genitourinary 98

Duodart 98

Overview 98

Sales forecast 99

Central Nervous system 100

Almorexant 100

Overview 100

Sales forecast 101

Lamictal 102

Overview 102

Sales forecast 103

Imigran/Imitrex 105

Overview 105

Sales forecast 106

Endocrinology 108

Avandia 108

Overview 108

Sales forecast 109

Chapter 8 Appendix 112

R&D pipeline 112

Abbreviations 115

Exchange rates 116

About Datamonitor 117

About Datamonitor Healthcare 117

Datamonitor consulting 117

Disclaimer 119

Browse complete GlaxoSmithKline plc: PharmaVitae Profile Report

Browse all Healthcare Market Research Reports

Browse all Datamonitor Market Research Reports

Browse all Latest Report

Related Reports:

GlaxoSmithKline plc Market Share Analysis

GlaxoSmithKline plc-Company Report

GlaxoSmithKline Plc – SWOT Analysis

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/